Visual Training for Improving Intermittent Exotropia Visual Function
Launched by SHANGHAI EYE DISEASE PREVENTION AND TREATMENT CENTER · Sep 10, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether virtual reality (VR) and augmented reality (AR) visual training can help improve vision in children with a condition called intermittent exotropia, which causes one eye to turn outward at times. The main question the researchers want to answer is if this type of training can enhance the ability to see in three dimensions, known as stereoscopic vision.
Children aged 6 to 14 who meet certain criteria may be eligible to participate. To qualify, they need to have a specific type of eye misalignment and meet certain vision standards. Participants in the study will receive 20 minutes of VR/AR visual training each day for a year and will have check-ups at the hospital every three months to track their progress. It's important to note that children who have other eye conditions or certain health issues may not be eligible. Parents and guardians must agree to let their child participate and sign a consent form. This trial is currently not yet recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 6 to 14 years. Intermittent exotropia meeting all of the following criteria: Exodeviation at least 10Δ at distance measured by the prism and alternate cover test, near deviation does not exceed distance deviation by more than 10Δby prism and alternate cover test, mean distance Newcastle Control Score (NCS)≥2 points (mean of 3 assessments during the examination).
- • Refractive error between -5.00 D \< spherical equivalents (SEs) ≤ -1.00 D, astigmatism ≤1.50D, anisometropia ≤1.5D, best visual acuity in each eye of 1.0.
- • Not receiving any other form of strabismus or myopia treatment within 3 months. Willing to follow the research plan and participate in the entire research process.
- • Participants and guardians agree to be randomly assigned and sign an informed consent form.
- Exclusion Criteria:
- • Vertical strabismus; Diagnosed with other eye diseases or visual abnormalities such as strabismus, amblyopia, etc; Existence of cognitive or learning disabilities that may affect the effectiveness of training; patients with neurological disorders; Unable to cooperate with eye examination and follow-up work.
About Shanghai Eye Disease Prevention And Treatment Center
The Shanghai Eye Disease Prevention and Treatment Center is a leading clinical research organization dedicated to advancing the understanding and treatment of ocular diseases. With a strong emphasis on innovation and patient-centered care, the center collaborates with various stakeholders, including academic institutions and healthcare providers, to conduct rigorous clinical trials. Its mission is to enhance eye health outcomes through evidence-based research, contributing to the global body of knowledge in ophthalmology. The center is committed to fostering a culture of excellence in clinical practices, ensuring the highest standards of safety and efficacy in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported